ConductScience.org, home

Paper806263

BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.

Wald ER and 4 others. Antimicrob Agents Chemother, 1975. Cited by 38 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa. Papers, record 806263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/806263

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1975
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
2.15
iCite
Revised in PubMed
2021-05-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wald ERE R
2Standiford HCH C
3Tatem BAB A
4Calia FMF M
5Hornick RBR B

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarbenicillinMajor topic
GentamicinsMajor topic
PenicillinsMajor topic
Pseudomonas aeruginosaMajor topic
TicarcillinMajor topic
Drug Combinations
Guanidines
Penicillanic Acid

Source PubMed

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,157,342Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4157342PubMed
25,000,263-carboxy-3-thienylmethylpenicillin (BRL 2288), a new semisynthetic penicillin: in vitro evaluation.Antimicrob Agents Chemother (Bethesda)1970https://conductscience.org/library/papers/5000263PubMed
34,180,218Resistance of Pseudomonas aeruginosa to carbenicillin.Lancet1969https://conductscience.org/library/papers/4180218PubMed
44,407,110The hemostatic defect produced by carbenicillin.N Engl J Med1974https://conductscience.org/library/papers/4407110PubMed
54,711,781Carbenicillin and hypokalemia.Ann Intern Med1973https://conductscience.org/library/papers/4711781PubMed
64,989,316Carbenicillin: a clinical and laboratory evaluation.Ann Intern Med1970https://conductscience.org/library/papers/4989316PubMed
74,959,982Simplified, accurate method for antibiotic assay of clinical specimens.Appl Microbiol1966https://conductscience.org/library/papers/4959982PubMed
84,897,133Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966.Medicine (Baltimore)1969https://conductscience.org/library/papers/4897133PubMed
94,924,999In vitro studies of alpha-carboxyl-3-thienylmethyl penicillin, a new semisynthetic penicillin.Appl Microbiol1971https://conductscience.org/library/papers/4924999PubMed
104,871,700The importance of underlying disease in patients with gram-negative bacteremia.Arch Intern Med1968https://conductscience.org/library/papers/4871700PubMed
116,061,541Gram-negative septicemia: a growing threat.Ann Surg1967https://conductscience.org/library/papers/6061541PubMed

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
19,564,363
Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19564363PubMed
7,002,527Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.Drugs1980https://conductscience.org/library/papers/7002527PubMed
6,225,391Early synergistic interaction between semisynthetic penicillins and aminoglycosidic aminocyclitols against Enterobacteriaceae.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6225391PubMed
3,311,531Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.Clin Pharmacokinet1987https://conductscience.org/library/papers/3311531PubMed
3,300,527Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3300527PubMed
3,069,193Antibiotic combinations: should they be tested?Clin Microbiol Rev1988https://conductscience.org/library/papers/3069193PubMed
2,113,159Synergistic activity of aminoglycoside-beta-lactam combinations against Pseudomonas aeruginosa with an unusual aminoglycoside antibiogram.Med Microbiol Immunol1990https://conductscience.org/library/papers/2113159PubMed
984,764Comparative activity in vitro of ticarcillin, BL-P1654, and carbenicillin.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984764PubMed
938,027Laboratory studies with a new broad-spectrum penicillin, pirbenicillin.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/938027PubMed
817,659
Evaluation of antibiotic efficacy using electron microscopy: morphological effects of guanylureido cephalosporin, chlorobenzoylureido cephalosporin, BL-P1654, and carbenicillin on Pseudomonas aeruginosa.
Antimicrob Agents Chemother1976https://conductscience.org/library/papers/817659PubMed
816,248Comparative in vitro evaluation of the effects of ticarcillin and carbenicillin upon Psuedomonas aeruginosa.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/816248PubMed
795,373In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/795373PubMed
795,372Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/795372PubMed
406,837Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/406837PubMed
404,963Pirbenicillin: comparison with carbenicillin and BL-P1654, alone and with gentamicin, against Pseudomonas aeruginosa.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/404963PubMed
397,937[Fifty years of penicillins. A review of structure-effect relationships of beta-lactamase antibiotics and their microbiological and clinical relevance (author's transl)].Infection1979https://conductscience.org/library/papers/397937PubMed
98,109In vitro antibacterial activity of amikacin and ticarcillin, alone and in combination, against Pseudomonas aerurginosa.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/98109PubMed
96,736Unpredictable response of Pseudomonas aeruginosa to synergistic antibiotic combinations in vitro.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/96736PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/806263

GET https://conductscience.org/api/papers/v1/806263/authors